Log in to save to my catalogue

Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment

Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6272080

Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment

About this item

Full title

Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2018-12, Vol.109 (12), p.3707-3713

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Langerhans cell histiocytosis (LCH) is a rare systemic disorder characterized by the accumulation of CD1a+/Langerin+ LCH cells and wide‐ranging organ involvement. Langerhans cell histiocytosis was formerly referred to as histiocytosis X, until it was renamed in 1987. Langerhans cell histiocytosis β was named for its morphological similarity to skin...

Alternative Titles

Full title

Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6272080

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6272080

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.13817

How to access this item